image credit: Freepik

Cytovance Biologics now offering Licensing for Plasmid DNA Manufacturing

March 8, 2021

Via: BioSpace

Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and gene therapy plasmid DNA (pDNA), announces a licensing opportunity for pDNA manufacturing. The Keystone Expression System pDNA platform is an end-to-end solution for manufacturing GMP pDNA at scale in a manufacturer’s own facility.

Read More on BioSpace